Calcium, an essential mineral, plays a pivotal role in sustaining the health and function of the human skeletal system. Its significance in bone metabolism is a subject of great interest in medical science. This article aims to provide a comprehensive review of calcium's integral role in bone metabolism, elucidating its mechanisms and clinical implications.
Calcium is the most abundant mineral in the human body, with 99% stored in the bones and teeth. It contributes to bone strength and structure, and is involved in critical metabolic functions such as nerve transmission, muscle contraction, and blood clotting. The interplay between dietary calcium intake, absorption, excretion, and bone remodeling underscores its role in maintaining bone health.
Bone remodeling, a continuous process of bone formation and resorption, is significantly influenced by calcium levels. Osteoblasts (cells responsible for bone formation) and osteoclasts (cells responsible for bone resorption) work in tandem to maintain bone homeostasis. Any imbalance in this process, often linked to calcium deficiencies, can lead to bone diseases such as osteoporosis.
Calcium homeostasis is a tightly regulated process involving the parathyroid hormone (PTH) and vitamin D. PTH increases blood calcium levels by stimulating osteoclast activity and enhancing renal reabsorption of calcium. Vitamin D promotes intestinal absorption of calcium. Disruptions in this regulatory system can result in hypercalcemia or hypocalcemia, with potential adverse effects on cardiovascular, renal, and neurological health.
Understanding the integral role of calcium in bone metabolism is crucial for healthcare professionals. It informs the approach to prevention, diagnosis, and treatment of bone-related diseases. Further research into the complex interactions between calcium, bone health, and overall metabolism will undoubtedly enhance our ability to manage and prevent skeletal disorders effectively.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation